Fate therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Contact Fate Therapeutics

7 hours ago Fatetherapeutics.com

Contact. Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego, CA 92121. Coming from the North. 5 South to Genesee > Exit Right on Genesee > Right on John J Hopkins Dr > Right on General Atomics Ct. Fate is the first building on the right. Coming from the South.

Website: https://fatetherapeutics.com/contact/

Category: Contact SupportShow Details ››

Fate Therapeutics Inc B2B Contact Database Provider

Just Now Adapt.io

Find the Fate Therapeutics Inc company's Operations team/department contact details such as business emails, phone numbers, web address and other …

Website: https://www.adapt.io/company/fate-therapeutics-inc/operations-contacts

Category: Phone Number, Contact SupportShow Details ››

Fate Therapeutics Crunchbase Company Profile & Funding

7 hours ago Crunchbase.com

Contact Email [email protected] Phone Number 8588751802 Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics.

Founded: 2007
Founder: Rudolf Jaenisch

Website: https://www.crunchbase.com/organization/fate-therapeutics

Category: Cell Phone, Phone Number, Contact SupportShow Details ››

SEC Filing Fate Therapeutics, Inc.

7 hours ago Ir.fatetherapeutics.com

858.875.1803

FATE THERAPEUTICS INC: Street Address 1 Street Address 2; 3535 GENERAL ATOMICS COURT: SUITE 200: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; SAN DIEGO: CALIFORNIA: 92121: 858.875.1803

Website: https://ir.fatetherapeutics.com/node/10926/html

Category: Phone NumberShow Details ››

FT538 Fate Therapeutics

1 hours ago Fatetherapeutics.com

FT538. Multiple myeloma is a hematologic malignancy characterized by the proliferation of malignant plasma cells. In multiple myeloma, malignant plasma cells accumulate in the bone marrow and produce abnormal antibodies called M proteins, which can cause kidney damage, bone destruction, and impaired immune function. While multiple approved

Website: https://fatetherapeutics.com/pipeline/immuno-oncology-candidates/ft538/

Category: Cell PhoneShow Details ››

Management Fate Therapeutics

9 hours ago Fatetherapeutics.com

866.875.1833

©2021 Fate Therapeutics 3535 General Atomics Court, Suite 200, San Diego 92121 866.875.1833 LEGAL

Website: https://fatetherapeutics.com/about-us/management/

Category: Contact NumberShow Details ››

SEC Filing Fate Therapeutics, Inc.

7 hours ago Ir.fatetherapeutics.com

212.362.1200

Fate Therapeutics is providing the information in this release as of this date and does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise. Contact: Christina Tartaglia. Stern Investor Relations, Inc. 212.362.1200. [email protected]

Website: https://ir.fatetherapeutics.com/node/10956/html

Category: Contact SupportShow Details ››

Fate Therapeutics, Inc. (FATE) Company Profile & Facts

4 hours ago Finance.yahoo.com

See the company profile for Fate Therapeutics, Inc. (FATE) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

Website: https://finance.yahoo.com/quote/FATE/profile

Category: Contact NumberShow Details ››

Tom Lee Senior Director, Mole.. Fate Therapeutics

6 hours ago Zoominfo.com

View Tom Lee's business profile as Senior Director, Molecular Engineering at Fate Therapeutics. Find contact's direct phone number, email address, work history, and more.

Website: https://www.zoominfo.com/p/Tom-Lee/-1845768690

Category: Phone Number, Contact SupportShow Details ››

Early/Expanded Access Policy Fate Therapeutics

7 hours ago Fatetherapeutics.com

Fate Therapeutics is committed to developing safe and effective next-generation cellular immunotherapies for cancer and immune disorders. Our goal is to ensure access to our investigational cell therapies at the appropriate time and in a clinically appropriate manner for patients. Fate’s Early/Expanded Access Policy (EAP) refers to the use of an investigational cell therapy outside […]

Website: https://fatetherapeutics.com/pipeline/early-expanded-access-policy/

Category: Cell PhoneShow Details ››

Management Fate Therapeutics

2 hours ago Dev.fatetherapeutics.com

866.875.1833

©2021 Fate Therapeutics 3535 General Atomics Court, Suite 200, San Diego 92121 866.875.1833 LEGAL

Website: http://dev.fatetherapeutics.com/about-us/management/

Category: Contact NumberShow Details ››

Fate Therapeutics: Number of Employees 20122021 FATE

4 hours ago Macrotrends.net

Interactive chart of Fate Therapeutics (FATE) annual worldwide employee count from 2012 to 2021. Fate Therapeutics total number of employees in 2020 was 279, a 56.74% increase from 2019.; Fate Therapeutics total number of employees in 2019 was 178, a 71.15% increase from 2018.; Fate Therapeutics total number of employees in 2018 was 104, a 30% increase from 2017.

Website: https://www.macrotrends.net/stocks/charts/FATE/fate-therapeutics/number-of-employees

Category: Contact NumberShow Details ››

FATE Graham Number Fate Therapeutics GuruFocus.com

8 hours ago Gurufocus.com

Fate Therapeutics Graham Number Calculation. Graham Number is a concept based on Ben Graham's conservative valuation of companies. Fate Therapeutics's Graham Number for the fiscal year that ended in Dec. 2020 is calculated as

Website: https://www.gurufocus.com/term/grahamnumber/NAS:FATE/Graham-Number/Fate-Therapeutics-Inc

Category: Contact NumberShow Details ››

Fate Therapeutics Announces Six Presentations at the 2017

8 hours ago Ir.fatetherapeutics.com

Fate Therapeutics' iPSC product platform is supported by an intellectual property portfolio of over 90 issued patents and 100 pending patent applications. About Fate Therapeutics, Inc. Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders.

Website: https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-announces-six-presentations-2017-ash-annual

Category: Cell Phone, Support NumberShow Details ››

Fate Therapeutics Funding, Financials, Valuation & Investors

6 hours ago Crunchbase.com

Fate Therapeutics has raised a total of $360.2M in funding over 11 rounds. Their latest funding was raised on Sep 19, 2019 from a Post-IPO Equity round. Fate Therapeutics is registered under the ticker NASDAQ:FATE . Their stock opened with $6.00 in its Oct 4, 2013 IPO. Fate Therapeutics is …

Website: https://www.crunchbase.com/organization/fate-therapeutics/company_financials

Category: Contact NumberShow Details ››

Fate Therapeutics to Webcast Conference Call Reporting

1 hours ago Marketscreener.com

212.362.1200

Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com. Contact: Christina Tartaglia Stern Investor Relations, Inc. 212.362.1200 [email protected]

Website: https://www.marketscreener.com/quote/stock/FATE-THERAPEUTICS-INC-14297698/news/Fate-Therapeutics-to-Webcast-Conference-Call-Reporting-Second-Quarter-2021-Financial-Results-35872066/

Category: Contact SupportShow Details ››

Fate Therapeutics Total Employees (Annual) FATE

6 hours ago Ycharts.com

The Zacks Analyst Blog Highlights: Moderna, Ultragenyx Pharma, Fate Therapeutics, Intellia Therapeutics, and Mersana Therapeutics Yahoo 12/30 10:42 ET …

Website: https://ycharts.com/companies/FATE/total_employee_number

Category: Contact NumberShow Details ››

Fate Therapeutics Market Cap 20122021 FATE MacroTrends

5 hours ago Macrotrends.net

Fate Therapeutics market cap history and chart from 2012 to 2021. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Fate Therapeutics market cap as of July 16, 2021 is $7.39B.

Website: https://www.macrotrends.net/stocks/charts/FATE/fate-therapeutics/market-cap

Category: Contact NumberShow Details ››

Fate Therapeutics Highlights Positive Interim Data from its

6 hours ago Globenewswire.com

Fate Therapeutics Highlights Positive Interim Data from its Phase 1 Study of FT516 in Combination with Rituximab for B-cell Lymphoma at 2021 ASCO Annual Meeting. 6 of 11 Patients Achieved Complete

Website: https://www.globenewswire.com/news-release/2021/06/04/2241947/24675/en/Fate-Therapeutics-Highlights-Positive-Interim-Data-from-its-Phase-1-Study-of-FT516-in-Combination-with-Rituximab-for-B-cell-Lymphoma-at-2021-ASCO-Annual-Meeting.html

Category: Cell PhoneShow Details ››

Fate Therapeutics Announces Proposed Public Offering of

9 hours ago Finance.yahoo.com

SAN DIEGO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the

Website: https://finance.yahoo.com/news/fate-therapeutics-announces-proposed-public-210100601.html

Category: Contact NumberShow Details ››

Fate Therapeutics Announces Six Presentations at the 2019

8 hours ago Globenewswire.com

About Fate Therapeutics, Inc. looking statements in this release are based on management's current expectations of future events and are subject to a number of risks and uncertainties that

Website: https://www.globenewswire.com/news-release/2019/11/06/1942276/0/en/Fate-Therapeutics-Announces-Six-Presentations-at-the-2019-ASH-Annual-Meeting.html

Category: Contact NumberShow Details ››

Can Fate Therapeutics Stock Rebound After A 20% Drop? Nasdaq

4 hours ago Nasdaq.com

Ten Day: FATE 13%, vs. S&P500 1.8%; Outperformed market (20% likelihood event) Fate Therapeutics stock rose 13% over the last 10 trading days (2 weeks), compared to broader market (S&P500) rise of

Website: https://www.nasdaq.com/articles/can-fate-therapeutics-stock-rebound-after-a-20-drop-2021-04-01

Category: Contact NumberShow Details ››

Does Fate Therapeutics Inc (FATE) Have What it Takes to be

3 hours ago Investorsobserver.com

Fate Therapeutics Inc is near the top in its industry group according to InvestorsObserver.FATE gets an overall rating of 44. That means it scores higher than 44 percent of stocks. Fate Therapeutics Inc gets a 69 rank in the Biotechnology industry. Biotechnology is number 106 out of 148 industries.

Website: https://www.investorsobserver.com/news/stock-update/does-fate-therapeutics-inc-fate-have-what-it-takes-to-be-in-your-portfolio-monday

Category: Tech SupportShow Details ››

Fate Therapeutics Announces Treatment of First Patient in

4 hours ago Globenewswire.com

About Fate Therapeutics, Inc. looking statements in this release are based on management's current expectations of future events and are subject to a number of risks and uncertainties that

Website: https://www.globenewswire.com/da/news-release/2021/08/02/2273241/24675/en/Fate-Therapeutics-Announces-Treatment-of-First-Patient-in-Landmark-Phase-1-Clinical-Trial-of-FT819-the-First-ever-iPSC-derived-CAR-T-Cell-Therapy.html

Category: Contact NumberShow Details ››

Please leave your comments here:

1. How to become an investor in fate therapeutics?

Investors FAQs Contact One Cell. Many Fates. Transforming the lives of patients with cancer and immune disorders FT500 FT516 FT596 FT538 FT576 FT819 FT573 Press Releases ©2021 Fate Therapeutics

2. Why did fate therapeutics stock drop 20?

The stock price of Fate Therapeutics (NASDAQ:FATE), a biopharmaceuticals company focused on oncology and immunology treatments based on natural killer (NK) T-Cell programs, has seen a large 20% drop in just five trading sessions. The decline is driven in part by the broader sell-off in high growth stocks.

3. Who is the senior vice president of fate therapeutics?

Dr. Yu-Waye (Wayne) Chu is Senior Vice President, Clinical Development at Fate Therapeutics, overseeing the company’s clinical development strategies.

4. Who is the chief financial officer of fate?

Edward Dulac is Chief Financial Officer at Fate Therapeutics. Prior to joining Fate, Mr. Dulac served as Vice President of Business Development & Strategy at Celgene, where he was responsible for business development opportunities in the therapeutic areas of hematology and oncology, inflammation and immunology, and neuroscience.

Brand New Updated

Ca Lottery Contact Number

Matthews International Corp

Wordpress Contact Us Page

Franklin Financial Network

Pulte Homes Customer Service Number

Summit Broadband Customer Service Number

Pharmacy Technician Letter Contact Number

Laureate Education

Steamshipauthority.com

Delta Dental Florida Customer Service Number

Department Of Education Contact Numbers

Browse All Brands >>

Popular Brands

Ford
Fanuc
Fmc
Fedex
Fluent